Personal information

Activities

Collapse all

Employment (1)

Weill Cornell Medicine: New York, New York, US

1981-07-01 to present | Professor (Pediatrics)
Employment
Source: Self-asserted source
James Bussel

Works (39)

Inhibition of FcRn with rozanolixizumab in adults with immune thrombocytopenia: Two randomised, double‐blind, placebo‐controlled phase 3 studies and their open‐label extension

British Journal of Haematology
2025-02 | Journal article
DOI: 10.1111/bjh.19858
Contributors: Nichola Cooper; James B. Bussel; Maciej Kaźmierczak; Yoshitaka Miyakawa; Sarah Cluck; Rocío Lledó García; Birgit Haier; Andreea Lavrov; Puneet Singh; Rose Snipes et al.
Source: check_circle
Crossref

Familial autoimmunity and risk of developing immune thrombocytopenia and Evans syndrome

Pediatric Blood & Cancer
2024-10 | Journal article
DOI: 10.1002/pbc.31239
Contributors: Michell M. Lozano Chinga; James B. Bussel; Mark N. Fluchel; Jacob Wilkes; Chong Zhang; Huong Meeks; Jessica A. Meznarich
Source: check_circle
Crossref

What is the best second‐line treatment for immune thrombocytopenia?

British Journal of Haematology
2024-10 | Journal article
DOI: 10.1111/bjh.19777
Contributors: Matthieu Mahévas; James B. Bussel
Source: check_circle
Crossref

Unexpected diagnosis of WHIM syndrome in refractory autoimmune cytopenia

Blood Advances
2024-10-08 | Journal article
DOI: 10.1182/bloodadvances.2024013301
Contributors: Yolanda Garcia-Carmona; Jose Chavez; Yael Gernez; Julia T. Geyer; James B. Bussel; Charlotte Cunningham-Rundles
Source: check_circle
Crossref

Increased risk of haematological malignancy in adults over age 60 with thrombocytopenia compared with matched controls: Time for an upfront bone marrow evaluation?

British Journal of Haematology
2024-09 | Journal article
DOI: 10.1111/bjh.19649
Contributors: A. Vijenthira; A. S. Wilton; S. Lee; G. H. Tang; T. Gomes; J. B. Bussel; M. Sholzberg
Source: check_circle
Crossref

Immune thrombocytopenia (ITP) in pregnancy

British Journal of Haematology
2024-04 | Journal article
DOI: 10.1111/bjh.19230
Contributors: James B. Bussel; Katherine A. Knightly
Source: check_circle
Crossref

Does absence of intracranial hemorrhage in the first pregnancy in fetal and neonatal alloimmune thrombocytopenia preclude occurrence in the second?

American Journal of Hematology
2024-03 | Journal article
DOI: 10.1002/ajh.27193
Contributors: Katherine A. Knightly; James B. Bussel; Margaret McKelvy; Emilie Vander Haar
Source: check_circle
Crossref

Improving the chances of response to splenectomy in immune thrombocytopenia

British Journal of Haematology
2024-01 | Journal article
DOI: 10.1111/bjh.19174
Contributors: Sylvain Audia; James Bussel
Source: check_circle
Crossref

The highs and lows of cyclic thrombocytopenia

British Journal of Haematology
2024-01 | Journal article
DOI: 10.1111/bjh.19239
Contributors: Haiyu Zhang; Alejandro Villar‐Prados; James B. Bussel; James L. Zehnder
Source: check_circle
Crossref

Treatment of immune thrombocytopenia during pregnancy with thrombopoietin receptor agonists

British Journal of Haematology
2023-12 | Journal article
DOI: 10.1111/bjh.19161
Contributors: Amihai Rottenstreich; James B. Bussel
Source: check_circle
Crossref

Intramuscular anti‐D treatment for immune thrombocytopenia—Response

British Journal of Haematology
2023-11 | Journal article
DOI: 10.1111/bjh.19065
Contributors: James B. Bussel
Source: check_circle
Crossref

A tribute to Paul Imbach

British Journal of Haematology
2023-10 | Journal article
DOI: 10.1111/bjh.19071
Contributors: James B. Bussel
Source: check_circle
Crossref

The role of genetics in refractory immune thrombocytopenia

British Journal of Haematology
2023-10 | Journal article
DOI: 10.1111/bjh.19110
Contributors: James L. Zehnder; James B. Bussel; Nichola Cooper
Source: check_circle
Crossref

A phase 3, randomized, double‐blind, active‐controlled trial evaluating efficacy and safety of avatrombopag versus eltrombopag in ITP

British Journal of Haematology
2023-08 | Journal article
DOI: 10.1111/bjh.18908
Contributors: Michael D. Tarantino; James B. Bussel; Eun‐Ju Lee; Brian D. Jamieson
Source: check_circle
Crossref

Common‐sense combination therapy in refractory immune thrombocytopaenia

British Journal of Haematology
2023-08 | Journal article
DOI: 10.1111/bjh.18919
Contributors: Hanny Al‐Samkari; James B. Bussel
Source: check_circle
Crossref

Early initiation of second-line therapy in primary immune thrombocytopenia: insights from real-world evidence

Annals of Hematology
2023-08 | Journal article
DOI: 10.1007/s00277-023-05289-0
Contributors: Adam Cuker; Brian Buckley; Marie-Catherine Mousseau; Aditya Anand Barve; Jens Haenig; James B. Bussel
Source: check_circle
Crossref

Plasma gastric biomarker evaluation with avatrombopag dosing in patients with chronic immune thrombocytopenia in phase 3 trials

British Journal of Haematology
2023-08 | Journal article
DOI: 10.1111/bjh.18897
Contributors: James B. Bussel; Michael D. Tarantino; Eun‐Ju Lee; Brian D. Jamieson
Source: check_circle
Crossref

Maintenence rituximab following induction in autoimmune cytopenias

British Journal of Haematology
2023-07 | Journal article
DOI: 10.1111/bjh.18814
Contributors: Manoj P. Rai; Eun‐Ju Lee; James B. Bussel
Source: check_circle
Crossref

Why should intramuscular anti‐D be different from intravenous anti‐D?

British Journal of Haematology
2023-02 | Journal article
DOI: 10.1111/bjh.18524
Contributors: James B. Bussel
Source: check_circle
Crossref

Effects of COVID‐19 vaccination on platelet counts and bleeding in children, adolescents, and young adults with immune thrombocytopenia

Pediatric Blood & Cancer
2023-01 | Journal article
DOI: 10.1002/pbc.30051
Contributors: Shipra Kaicker; Kirsten Martinko; James B. Bussel
Source: check_circle
Crossref

Romiplostim use in pregnant women with immune thrombocytopenia

American Journal of Hematology
2023-01 | Journal article
DOI: 10.1002/ajh.26743
Contributors: James B. Bussel; Nichola Cooper; Tatiana Lawrence; Marc Michel; Emilie Vander Haar; Kejia Wang; Hongmei Wang; Hossam Saad
Source: check_circle
Crossref

Should dexamethasone alone or in combination be the initial steroid for adult ITP: Still a relevant question

British Journal of Haematology
2023-01 | Journal article
DOI: 10.1111/bjh.18398
Contributors: Barbara Skopec; James B. Bussel
Source: check_circle
Crossref

Treatment of immune thrombocytopenia with eltrombopag in patients who had and who had not received prior rituximab: post‐hoc analysis of the EXTEND study

British Journal of Haematology
2022-01 | Journal article
DOI: 10.1111/bjh.17800
Contributors: Oliver Meyer; Raymond S. M. Wong; Abderrahim Khelif; Miona Stankovic; Joan Maier; Mansoor N. Saleh; James B. Bussel
Source: check_circle
Crossref

Heritable platelet disorders: an enigma even guidelines can’t unravel

British Journal of Haematology
2021-10 | Journal article
DOI: 10.1111/bjh.17809
Contributors: James B. Bussel; Ellinor Peerschke
Source: check_circle
Crossref

Familial thrombocythaemia – a distinct entity from essential thrombocythaemia

British Journal of Haematology
2021-09 | Journal article
DOI: 10.1111/bjh.17701
Contributors: James Bussel; Nicole Kucine
Source: check_circle
Crossref

Immune thrombocytopenia during the COVID‐19 pandemic

British Journal of Haematology
2021-06 | Journal article
DOI: 10.1111/bjh.17457
Contributors: Eun‐Ju Lee; Xinguang Liu; Ming Hou; James B. Bussel
Source: check_circle
Crossref

Quality of life is an important indication for second‐line treatment in children with immune thrombocytopenia

Pediatric Blood & Cancer
2021-06 | Journal article
DOI: 10.1002/pbc.29023
Contributors: Kristin A. Shimano; Cindy Neunert; James B. Bussel; Robert J. Klaassen; Rukhmi Bhat; Yves D. Pastore; Michele P. Lambert; Carolyn M. Bennett; Jenny M. Despotovic; Peter Forbes et al.
Source: check_circle
Crossref

Fatigue in children and adolescents with immune thrombocytopenia

British Journal of Haematology
2020-10 | Journal article
DOI: 10.1111/bjh.16751
Contributors: Rachael F. Grace; Robert J. Klaassen; Kristin A. Shimano; Michele P. Lambert; Amanda Grimes; James B. Bussel; Vicky R. Breakey; Yves D. Pastore; Vandy Black; Kathleen Overholt et al.
Source: check_circle
Crossref

Fostamatinib is an effective second‐line therapy in patients with immune thrombocytopenia

British Journal of Haematology
2020-09 | Journal article
DOI: 10.1111/bjh.16959
Contributors: Ralph Boccia; Nichola Cooper; Waleed Ghanima; Michael A Boxer; Quentin A. Hill; Michelle Sholzberg; Michael D. Tarantino; Leslie K. Todd; Sandra Tong; James B. Bussel
Source: check_circle
Crossref

Combination of thrombopoietin receptor agonists, immunosuppressants and intravenous immunoglobulin as treatment of severe refractory immune thrombocytopenia in adults and children

British Journal of Haematology
2020-04 | Journal article
DOI: 10.1111/bjh.16426
Contributors: Sif Gudbrandsdottir; Emily Leven; Allison Imahiyerobo; Christina Soo Lee; James Bussel
Source: check_circle
Crossref

Long‐term sustained response to fostamatinib in two patients with chronic refractory immune thrombocytopenia (ITP)

British Journal of Haematology
2020-04 | Journal article
DOI: 10.1111/bjh.16328
Contributors: Eun‐Ju Lee; Marina Izak; James B. Bussel
Source: check_circle
Crossref

FAS mutations are an uncommon cause of immune thrombocytopenia in children and adults without additional features of immunodeficiency

British Journal of Haematology
2019-09 | Journal article
DOI: 10.1111/bjh.15979
Contributors: Jana Vandrovcova; Ulrich Salzer; Bodo Grimbacher; Jennifer Wanders; Konetti Rao; Adrian Thrasher; Siobhan Burns; Kimberley Gilmore; James Bussel; Nichola Cooper
Source: check_circle
Crossref

Response to thrombopoietic agents is related to on‐treatment bone marrow megakaryocyte morphology in patients with chronic immune thrombocytopenia

American Journal of Hematology
2019-07 | Journal article
DOI: 10.1002/ajh.25496
Contributors: Marie Hogan; Julia T. Geyer; James B. Bussel
Source: check_circle
Crossref

Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidence‐based practice, an international approach

British Journal of Haematology
2019-05 | Journal article
DOI: 10.1111/bjh.15813
Contributors: Lani Lieberman; Andreas Greinacher; Michael F. Murphy; James Bussel; Tamam Bakchoul; Stacy Corke; Mette Kjaer; Jens Kjeldsen‐Kragh; Gerald Bertrand; Dick Oepkes et al.
Source: check_circle
Crossref

Health‐related quality of life in children with chronic immune thrombocytopenia treated with eltrombopag in the PETIT study

British Journal of Haematology
2019-04 | Journal article
DOI: 10.1111/bjh.15732
Contributors: John D. Grainger; Victor S. Blanchette; Kelly M. Grotzinger; Anuja Roy; James B. Bussel
Source: check_circle
Crossref

Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo‐controlled trials

American Journal of Hematology
2018-07 | Journal article
DOI: 10.1002/ajh.25125
Contributors: James Bussel; Donald M. Arnold; Elliot Grossbard; Jiří Mayer; Jacek Treliński; Wojciech Homenda; Andrzej Hellmann; Jerzy Windyga; Liliya Sivcheva; Alhossain A. Khalafallah et al.
Source: check_circle
Crossref

Physician decision making in selection of second‐line treatments in immune thrombocytopenia in children

American Journal of Hematology
2018-07 | Journal article
DOI: 10.1002/ajh.25110
Contributors: Rachael F. Grace; Jenny M. Despotovic; Carolyn M. Bennett; James B. Bussel; Michelle Neier; Cindy Neunert; Shelley E. Crary; Yves D. Pastore; Robert J. Klaassen; Jennifer A. Rothman et al.
Source: check_circle
Crossref

Imaging and management of fetuses and neonates with alloimmune thrombocytopenia

Pediatric Blood & Cancer
2017-12 | Journal article
DOI: 10.1002/pbc.26690
Contributors: Arzu Kovanlikaya; Priyanka Tiwari; James B. Bussel
Source: check_circle
Crossref

TPO for ITP in pregnancy

Blood
2017-08-31 | Journal article
DOI: 10.1182/blood-2017-07-793356
Contributors: James B. Bussel; Eun-Ju Lee
Source: check_circle
Crossref
How many people are using ORCID?